Brief: SMS Lifesciences India March-Qtr Consol Net Profit Drops
July 27 (Reuters) - SMS Lifesciences India Ltd SMSL.NS :
* MARCH-QUARTER CONSOL NET PROFIT 15.7 MILLION RUPEES VERSUS
46
MILLION RUPEES YEAR AGO
* MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 459.9 MILLION
RUPEES VERSUS 1.07 BILLION RUPEES YEAR AGO
Source text for Eikon: ID:nBSE3dC73V
Further company coverage: SMSL.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Haleos Labs
See all newsBrief: Haleos Labs Entered Into Strategic Development Collaboration With Hrv Global Life Sciences
SMS Lifesciences India soars; facility gets US FDA clearance
Brief: SMS Lifesciences India Gets EIR With VAI Status From USFDA
Brief: SMS Lifesciences India Dec-Quarter Consol Net Profit Rises
Brief: Sms Lifesciences India Sept-Qtr Consol Net Profit Falls